Valacyclovir for Mild Cognitive Impairment

Summary

Valacyclovir for Mild Cognitive Impairment is a clinical trial^[1].

Key Facts

• Valacyclovir for Mild Cognitive Impairment is in the country of United States^[2].
• Valacyclovir for Mild Cognitive Impairment's instance of is recorded as clinical trial^[3].
• Valacyclovir for Mild Cognitive Impairment's start time is recorded as +2021-02-01T00:00:00Z^[4].
• Valacyclovir for Mild Cognitive Impairment's end time is recorded as +2023-02-01T00:00:00Z^[5].
• Valacyclovir for Mild Cognitive Impairment's main subject is recorded as valacyclovir^[6].
• Valacyclovir for Mild Cognitive Impairment's main subject is recorded as herpes simplex^[7].
• Valacyclovir for Mild Cognitive Impairment's main subject is recorded as cognitive dysfunction^[8].
• Valacyclovir for Mild Cognitive Impairment's number of participants is recorded as {'unit': '1', 'amount': '+50'}^[9].
• Valacyclovir for Mild Cognitive Impairment's title is recorded as Anti Viral Treatment in Mild Cognitive Impairment^[10].
• Valacyclovir for Mild Cognitive Impairment's short name is recorded as VALMCI^[11].
• Valacyclovir for Mild Cognitive Impairment's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}^[12].
• Valacyclovir for Mild Cognitive Impairment's ClinicalTrials.gov ID is recorded as NCT04710030^[13].
• Valacyclovir for Mild Cognitive Impairment's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+95'}^[14].
• Valacyclovir for Mild Cognitive Impairment's research intervention is recorded as valacyclovir^[15].
• Valacyclovir for Mild Cognitive Impairment's clinical trial phase is recorded as phase II clinical trial^[16].
• Valacyclovir for Mild Cognitive Impairment's research subject recruitment status is recorded as not yet recruiting^[17].
• Valacyclovir for Mild Cognitive Impairment's study type is recorded as interventional study^[18].